BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8356553)

  • 1. [Accidents with antivitamin K. Advantages of benefits over risks].
    Manet P; Agniel B; Biour M
    Therapie; 1993; 48(1):64-5. PubMed ID: 8356553
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intracranial and intraspinal hemorrhage during anticoagulant therapy. Analysis of 52 cases].
    Desbordes JM; Deglaire B; Hulin A; Desplat A; Roualdes G
    Cah Anesthesiol; 1984 Mar; 32(3):209-12. PubMed ID: 6529657
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of complications with antivitamin K in elderly people].
    Pautas E; Mitha N; Gouronnec A; Siguret V; Gouin-Thibault I
    Soins Gerontol; 2011; (89):12-6. PubMed ID: 21698957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The adult intensive care physician and antivitamin K agents].
    Auzépy P; Rimailho A; Souied G; Riou B
    Agressologie; 1983 Nov; 24(11):549-54. PubMed ID: 6367510
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral anticoagulants: managing the hemorrhagic risk after 75 years].
    Pautas É
    Rev Prat; 2015 Sep; 65(7):897-9. PubMed ID: 26619720
    [No Abstract]   [Full Text] [Related]  

  • 6. [A retrospective study of the cause, treatment and course of cerebral hemorrhages during oral anticoagulant treatment].
    Wintzen AR; Klasen L; Bussemaker W; Broekmans AW; Loeliger EA
    Ned Tijdschr Geneeskd; 1988 Nov; 132(47):2151-4. PubMed ID: 3205332
    [No Abstract]   [Full Text] [Related]  

  • 7. [When is antivitamin K therapy indicated in the stable coronary patient?].
    Ferrari E; Serre S; Lesto I; Berkane N; Baudouy M
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1274-7. PubMed ID: 11794969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5 cases of fatal hemorrhagic accidents during prolonged anticoagulant treatments].
    Chassagnon C; Boisson M; Faguer P
    J Med Lyon; 1970 Jan; 51(179):409-10 passim. PubMed ID: 5526567
    [No Abstract]   [Full Text] [Related]  

  • 9. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tay KH; Lip GY; Lane DA
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antithrombotic therapy of atrial fibrillation].
    Chalon S; Lechat P
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1533-42. PubMed ID: 9092415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties].
    Ferrari E; Schiano N; Benhamou M; Baudouy M
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1301-6. PubMed ID: 11794973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ambulatory therapy with antivitamins K].
    Caviezel O
    Schweiz Rundsch Med Prax; 1971 Jan; 60(3):80-2. PubMed ID: 5549861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Massive right auricular and ventricular thrombosis after Kaskadil administration in a patient with an overdose of antivitamin K].
    Bonnet A; Rimmelé T; Crozon J; Pruvot S
    Ann Fr Anesth Reanim; 2008 Apr; 27(4):348-9. PubMed ID: 18403177
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment for overdose of oral anticoagulants].
    Lourenço DM; Morelli VM; Vignal CV
    Arq Bras Cardiol; 1998 Jan; 70(1):9-13. PubMed ID: 9629681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic education of patients taking antivitamin K anticoagulants].
    Chatelier R; Martinez R; Passeron M
    Soins; 2003 May; Spec No 2():14-5. PubMed ID: 12820299
    [No Abstract]   [Full Text] [Related]  

  • 16. [Risk of vitamin K antagonists in cases of cerebral microbleeds].
    Verhaar BJH; Vernooij MW; Biessels GJ; Muller M
    Ned Tijdschr Geneeskd; 2018; 162():D1790. PubMed ID: 29424326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Occult intrapulmonary hemorrhage during anticoagulant treatment].
    Granthil C; Dugue P; Houvenaeghel M; François G
    Nouv Presse Med; 1980 Nov; 9(43):3275. PubMed ID: 7454574
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
    Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
    Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intramural hematoma of the digestive tract from vitamin K antagonists].
    Costecalde M; Pradère B; Parent Y; Barret A; Gouzi JL; Gédéon A
    Ann Chir; 1984 Feb; 38(1):31-6. PubMed ID: 6608911
    [No Abstract]   [Full Text] [Related]  

  • 20. [Monitoring antivitamin K treatment: a notebook for the patient].
    Buxeraud J
    Rev Infirm; 2004 Apr; (100):38-41. PubMed ID: 15222184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.